cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Applied Molecular Transport
4 own
6 watching
Current Price
$0.27
$0.01
(1.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
10.58M
52-Week High
52-Week High
4.17
52-Week Low
52-Week Low
0.2105
Average Volume
Average Volume
0.24M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization10.58M
icon52-Week High4.17
icon52-Week Low0.2105
iconAverage Volume0.24M
iconDividend Yield--
iconP/E Ratio--
What does the Applied Molecular Transport do?
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company s lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Read More
How much money does Applied Molecular Transport make?
News & Events about Applied Molecular Transport.
Ticker Report
2 months ago
Chardan Capital cut shares of Applied Molecular Transport (NASDAQ:AMTI Get Rating) from a buy rating to a neutral rating in a research report report published on Tuesday, The Fly reports. A number of other research analysts have also recently weighed in on the stock. Bank of America cut ...
Zolmax
2 months ago
Applied Molecular Transport (NASDAQ:AMTI Get Rating) and Vascular Biogenics (NASDAQ:VBLT Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, ...
Globe Newswire
2 months ago
New positive data demonstrate oral AMT-101s gut-restricted profile with tissue-level pharmacodynamics (PD) effects and no systemic exposure by design Translational analysis reveals IL-10 biological responses in both 3mg and 10mg dose arms SOUTH SAN FRANCISCO, Calif., March 03, 2023 (GLOBE NEWSWIRE...
Benzinga
5 months ago
Gainers read more...
Globe Newswire
6 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced its participation at the following investor conferences: Event: Guggenheim 4th Annual Immunology and Neurology DayFormat: ...
Frequently Asked Questions
Frequently Asked Questions
What is Applied Molecular Transport share price today?
plus_minus_icon
Can Indians buy Applied Molecular Transport shares?
plus_minus_icon
How can I buy Applied Molecular Transport shares from India?
plus_minus_icon
Can Fractional shares of Applied Molecular Transport be purchased?
plus_minus_icon
What are the documents required to start investing in Applied Molecular Transport stocks?
plus_minus_icon
What is today’s traded volume of Applied Molecular Transport?
plus_minus_icon
What is today’s market capitalisation of Applied Molecular Transport?
plus_minus_icon
What is the 52-Week High and Low Range of Applied Molecular Transport?
plus_minus_icon
What percentage is Applied Molecular Transport down from its 52-Week High?
plus_minus_icon
What percentage is Applied Molecular Transport up from its 52-Week Low?
plus_minus_icon
Current Price
$0.27
$0.01
(1.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00